Neuronetics, Inc. NRC.F Stock
Neuronetics, Inc. Price Chart
Neuronetics, Inc. NRC.F Financial and Trading Overview
Neuronetics, Inc. stock price | 3.99 EUR |
Previous Close | 1.98 EUR |
Open | 1.92 EUR |
Bid | 2.1 EUR x 0 |
Ask | 2.18 EUR x 0 |
Day's Range | 1.92 - 1.92 EUR |
52 Week Range | 1.7 - 6.54 EUR |
Volume | 700 EUR |
Avg. Volume | 0 EUR |
Market Cap | 61.16M EUR |
Beta (5Y Monthly) | 1.927631 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.98 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 17.5 EUR |
NRC.F Valuation Measures
Enterprise Value | 41.22M EUR |
Trailing P/E | N/A |
Forward P/E | -2.2904763 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.91873926 |
Price/Book (mrq) | 1.1330978 |
Enterprise Value/Revenue | 0.619 |
Enterprise Value/EBITDA | -1.271 |
Trading Information
Neuronetics, Inc. Stock Price History
Beta (5Y Monthly) | 1.927631 |
52-Week Change | -31.86% |
S&P500 52-Week Change | 20.43% |
52 Week High | 6.54 EUR |
52 Week Low | 1.7 EUR |
50-Day Moving Average | 2.04 EUR |
200-Day Moving Average | 3.8 EUR |
NRC.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 28.5M |
Float | 22.6M |
Short Ratio | N/A |
% Held by Insiders | 5.30% |
% Held by Institutions | 68.07% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -55.34% |
Operating Margin (ttm) | -51.50% |
Gross Margin | 75.75% |
EBITDA Margin | -48.73% |
Management Effectiveness
Return on Assets (ttm) | -18.34% |
Return on Equity (ttm) | -58.97% |
Income Statement
Revenue (ttm) | 66.57M EUR |
Revenue Per Share (ttm) | 2.44 EUR |
Quarterly Revenue Growth (yoy) | 9.59% |
Gross Profit (ttm) | 49.72M EUR |
EBITDA | -32438000 EUR |
Net Income Avi to Common (ttm) | -36841000 EUR |
Diluted EPS (ttm) | -1.07 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 55.44M EUR |
Total Cash Per Share (mrq) | 1.95 EUR |
Total Debt (mrq) | 40.29M EUR |
Total Debt/Equity (mrq) | 83.33 EUR |
Current Ratio (mrq) | 5.361 |
Book Value Per Share (mrq) | 1.698 |
Cash Flow Statement
Operating Cash Flow (ttm) | -33770000 EUR |
Levered Free Cash Flow (ttm) | -18080624 EUR |
Profile of Neuronetics, Inc.
Country | Germany |
State | PA |
City | Malvern |
Address | 3222 Phoenixville Pike |
ZIP | 19355 |
Phone | 610 640 4202 |
Website | https://neurostar.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 200 |
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Q&A For Neuronetics, Inc. Stock
What is a current NRC.F stock price?
Neuronetics, Inc. NRC.F stock price today per share is 3.99 EUR.
How to purchase Neuronetics, Inc. stock?
You can buy NRC.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Neuronetics, Inc.?
The stock symbol or ticker of Neuronetics, Inc. is NRC.F.
Which industry does the Neuronetics, Inc. company belong to?
The Neuronetics, Inc. industry is Diagnostics & Research.
How many shares does Neuronetics, Inc. have in circulation?
The max supply of Neuronetics, Inc. shares is 30.07M.
What is Neuronetics, Inc. Price to Earnings Ratio (PE Ratio)?
Neuronetics, Inc. PE Ratio is now.
What was Neuronetics, Inc. earnings per share over the trailing 12 months (TTM)?
Neuronetics, Inc. EPS is -0.98 EUR over the trailing 12 months.
Which sector does the Neuronetics, Inc. company belong to?
The Neuronetics, Inc. sector is Healthcare.